Our results show that S1PR1 attenuates arthritis by increasing microvascular barrier function, and they reveal what we believe is a heretofore-undescribed mechanism for this effect of S1PR1: restraint of a metalloproteinase that cleaves VE-cadherin. The gene discussed is S1PR1; the disease is arthritic joint disease.